Scalper1 News
Drugmakers The Medicines Company (MDCO) and Eagle Pharmaceuticals (EGRX) were both rising on bullish analyst actions Monday in the wake of Thursday’s court ruling overturning the patents on Medicines’ cardiovascular drug Angiomax, or bivalirudin. The appeals-court decision would seem to be bad news for Medicines, but Mizuho Securities analyst Mario Corso upgraded the stock to buy from neutral Monday on the grounds that fears about the decision had Scalper1 News
Scalper1 News